The Supercrit® process is based on delipidation of bone tissue using CO2 in supercritical state, combined with chemical oxidation of the residual proteins contained in the pores of the cancellous tissue.
Due to its low viscosity and its high solvency properties, supercritical CO2 has an incomparable delipidating efficacy without aggressive action on the bone matrix.
Discover Supercrit®
BIOBank undertakes to offer products and services of irreproachable quality.
By applying the strictest standards and regulations, BIOBank guarantees the safety of its products.
To meet the current and future needs of surgeons and patients, BIOBank increasingly invests in research and development.
BIOBank is aware of its mission in the service of health and of its responsibility.
BIOBank is ISO 13485 certified and FDA registered.
To ensure the safety of the receivers, we control the entire chain of implementation of the grafts. Our transparent approach ensures a constant quality of tissues and processed products.
Biobank activities are subject to an authorisation issued by the ANSM. Similarly, the bone grafts benefit from a single marketing authorisation issued by the ANSM. BIOBank also has an export authorisation for its grafts.
Innovation is a main purpose of the BIOBank’s corporate project. Being the first tissue bank in the world using the patented supercritical fluids technology to degrease and viro-inactivate bone allografts, BIOBank has been innovative from the outset.
Bone powder is provided in a syringe with a specifically developed design. This innovation enables the surgeon to rehydrate bone tissue in a semi-closed system, guarantee of optimal asepsis and, to dispense the rehydrated powder directly in the grafting site. This innovation has highly efficient applications as small fillings in oral surgery and arthrodesis in neurosurgery.
By implementing sophisticated technologies based on the analyses of scanner images, 3D modelling an printing and machining on a digital centre, BIOBank is the only tissue bank to offer pre-machined bone grafts, perfectly adapted to the patient’s bone anatomy. This approach constitutes a real revolution for the quality of bone reconstruction and the comfort of patients by minimising surgical time and postoperative effects.
In scientific partnership with several academic laboratories, BIOBank invests in new forms and formulations with increased bioactivity. BIOBank is determined to always remain at the forefront of innovation in order to provide surgeons with high added scientific value products, for performance and clinical efficacy.
